PortfoliosLab logoPortfoliosLab logo
UNCY vs. MIST
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

UNCY vs. MIST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Unicycive Therapeutics Inc (UNCY) and Milestone Pharmaceuticals Inc. (MIST). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, UNCY achieves a 24.78% return, which is significantly higher than MIST's -36.63% return.


UNCY

1D
-0.41%
1M
-9.77%
YTD
24.78%
6M
16.69%
1Y
-5.64%
3Y*
-19.69%
5Y*
10Y*

MIST

1D
-3.03%
1M
-32.45%
YTD
-36.63%
6M
-51.15%
1Y
-24.26%
3Y*
-30.18%
5Y*
-25.32%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

UNCY vs. MIST - Yearly Performance Comparison


2026 (YTD)20252024202320222021
UNCY
Unicycive Therapeutics Inc
24.78%-27.35%-8.47%60.69%-73.79%-58.80%
MIST
Milestone Pharmaceuticals Inc.
-36.63%-14.41%41.32%-57.83%-39.54%19.09%

Correlation

The correlation between UNCY and MIST is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.27

Correlation (3Y)
Calculated over the trailing 3-year period

0.19

Correlation (All Time)
Calculated using the full available price history since Jul 13, 2021

0.14

The correlation between UNCY and MIST shifts across timeframes, from 0.14 (all time) to 0.27 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

UNCY:

$1.72B

MIST:

$166.77M

EPS

UNCY:

-$0.37

MIST:

-$0.49

PB Ratio

UNCY:

45.66

MIST:

4.63

Total Revenue (TTM)

UNCY:

$0.00

MIST:

$1.78M

Gross Profit (TTM)

UNCY:

$0.00

MIST:

$1.75M

EBITDA (TTM)

UNCY:

-$35.07M

MIST:

-$63.04M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

UNCY vs. MIST — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UNCY
UNCY Risk / Return Rank: 4141
Overall Rank
UNCY Sharpe Ratio Rank: 3838
Sharpe Ratio Rank
UNCY Sortino Ratio Rank: 4444
Sortino Ratio Rank
UNCY Omega Ratio Rank: 4646
Omega Ratio Rank
UNCY Calmar Ratio Rank: 3838
Calmar Ratio Rank
UNCY Martin Ratio Rank: 3838
Martin Ratio Rank

MIST
MIST Risk / Return Rank: 3131
Overall Rank
MIST Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
MIST Sortino Ratio Rank: 3434
Sortino Ratio Rank
MIST Omega Ratio Rank: 3434
Omega Ratio Rank
MIST Calmar Ratio Rank: 2929
Calmar Ratio Rank
MIST Martin Ratio Rank: 2727
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UNCY vs. MIST - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Unicycive Therapeutics Inc (UNCY) and Milestone Pharmaceuticals Inc. (MIST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


UNCYMISTDifference

Sharpe ratio

Return per unit of total volatility

-0.06

-0.29

+0.23

Sortino ratio

Return per unit of downside risk

0.55

0.15

+0.39

Omega ratio

Gain probability vs. loss probability

1.08

1.02

+0.06

Calmar ratio

Return relative to maximum drawdown

-0.10

-0.37

+0.27

Martin ratio

Return relative to average drawdown

-0.15

-0.73

+0.58

UNCY vs. MIST - Sharpe Ratio Comparison

The current UNCY Sharpe Ratio is -0.06, which is higher than the MIST Sharpe Ratio of -0.29. The chart below compares the historical Sharpe Ratios of UNCY and MIST, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


UNCYMISTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.06

-0.29

+0.23

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.33

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.27

-0.28

+0.01

Drawdowns

UNCY vs. MIST - Drawdown Comparison

The maximum UNCY drawdown since its inception was -95.97%, roughly equal to the maximum MIST drawdown of -97.60%. Use the drawdown chart below to compare losses from any high point for UNCY and MIST.


Loading charts...

Drawdown Indicators


UNCYMISTDifference

Max Drawdown

Largest peak-to-trough decline

-95.97%

-97.60%

+1.63%

Max Drawdown (1Y)

Largest decline over 1 year

-58.44%

-65.76%

+7.32%

Max Drawdown (3Y)

Largest decline over 3 years

-86.82%

-83.68%

-3.14%

Max Drawdown (5Y)

Largest decline over 5 years

-93.13%

Current Drawdown

Current decline from peak

-87.69%

-95.29%

+7.60%

Average Drawdown

Average peak-to-trough decline

-82.91%

-78.27%

-4.64%

Ulcer Index

Depth and duration of drawdowns from previous peaks

37.49%

33.40%

+4.09%

Volatility

UNCY vs. MIST - Volatility Comparison

Unicycive Therapeutics Inc (UNCY) has a higher volatility of 19.24% compared to Milestone Pharmaceuticals Inc. (MIST) at 17.85%. This indicates that UNCY's price experiences larger fluctuations and is considered to be riskier than MIST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


UNCYMISTDifference

Volatility (1M)

Calculated over the trailing 1-month period

19.24%

17.85%

+1.39%

Volatility (6M)

Calculated over the trailing 6-month period

45.99%

58.81%

-12.82%

Volatility (1Y)

Calculated over the trailing 1-year period

89.27%

83.35%

+5.92%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

119.64%

77.69%

+41.95%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

119.64%

105.36%

+14.28%

Dividends

UNCY vs. MIST - Dividend Comparison

Neither UNCY nor MIST has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

UNCY vs. MIST - Financials Comparison

This section allows you to compare key financial metrics between Unicycive Therapeutics Inc and Milestone Pharmaceuticals Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M202220232024202520260
238.00K
(UNCY) Total Revenue
(MIST) Total Revenue
Values in USD except per share items

Frequently Asked Questions


UNCY and MIST have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

UNCY has higher volatility (19.24%) compared to MIST (17.85%). In terms of maximum drawdown, UNCY dropped -95.97% vs MIST's -97.60%.

UNCY currently has the higher Sharpe Ratio (-0.06 vs -0.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for UNCY and MIST

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer